Circulating Tumor Microemboli Diagnostics for Patients with Non-Small Cell Lung Cancer

INTRODUCTION: Circulating Tumor Microemboli (CTM) are potentially important cancer biomarkers, but using them for cancer detection in early stage disease has been assay limited. We examined CTM test performance using a sensitive detection platform to identify stage I Non-Small Cell Lung Cancer (NSCL...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Carlsson, Anders, Nair, Viswam S., Luttgen, Madelyn S., Keu, Khun Visith, Horng, George, Vasanawala, Minal, Kolatkar, Anand, Jamali, Mehran, Iagaru, Andrei H., Kuschner, Ware, Loo, Billy W., Shrager, Joseph B., Bethel, Kelly, Hoh, Carl K., Bazhenova, Lyudmila, Nieva, Jorge, Kuhn, Peter, Gambhir, Sanjiv S.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2014
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4145608/
https://ncbi.nlm.nih.gov/pubmed/25157764
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/JTO.0000000000000235
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak